AMERIPRISE FINANCIAL INC

Position in ABBV — AbbVie Inc.

CIK 820027 MINNEAPOLIS, MN

Back to ABBV Full portfolio

Position in ABBV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,898,768,740

+$491,522,002 QoQ

Shares Held

11,519,507

+4.1% QoQ

Ownership

0.652%

of shares outstanding

% of Portfolio

0.73%

of 13F equity value

Holder Rank

#23

of 4,153 holders

Holding Since

Mar 2020

26 quarters on record

Voting authority Sole 0% Shared 75% None 25%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

AMERIPRISE FINANCIAL INC holds $17,081,497,167 across 17 Drug Manufacturers - General names. ABBV ranks #3 (17.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	2,996,669	$3,594,294,994
2	JNJ	Johnson & Johnson	13,401,691	$3,403,627,461
3	ABBV	AbbVie Inc. This page	11,519,507	$2,898,768,740
4	MRK	Merck & Co., Inc.	17,387,435	$2,234,285,396
5	BMY	Bristol Myers Squibb Co	26,670,064	$1,536,729,084
6	AZN	Astrazeneca PLC	6,095,430	$1,155,815,432
7	GILD	Gilead Sciences, Inc.	7,618,082	$962,468,477
8	AMGN	Amgen Inc	1,897,321	$687,057,877

All Filings in ABBV

Export CSV

26 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,898,768,740	11,519,507	+4.1%	Shares	Defined	2026-08-14
2026-03-31	$2,407,246,738	11,068,310	+10.0%	Shares	Defined	2026-05-15
2025-12-31	$2,298,755,173	10,060,638	+4.0%	Shares	Defined	2026-02-17
2025-09-30	$2,240,352,557	9,675,877	+4.4%	Shares	Defined	2025-11-14
2025-06-30	$1,720,224,251	9,267,451	-25.2%	Shares	Defined	2025-08-14
2025-03-31	$2,597,071,844	12,395,341	-4.9%	Shares	Defined	2025-05-14
2024-12-31	$2,315,549,700	13,030,668	-5.8%	Shares	Defined	2025-02-14
2024-09-30	$2,733,144,524	13,840,108	-1.5%	Shares	Defined	2024-11-14
2024-06-30	$2,409,791,334	14,049,623	-1.1%	Shares	Defined	2024-08-14
2024-03-31	$2,586,586,091	14,204,207	+0.1%	Shares	Defined	2024-05-15
2023-12-31	$2,199,352,368	14,192,117	+0.9%	Shares	Defined	2024-02-14
2023-09-30	$2,096,690,180	14,066,082	+1.4%	Shares	Defined	2023-11-14
2023-06-30	$1,868,199,724	13,866,249	-5.8%	Shares	Defined	2023-08-14
2023-03-31	$2,345,573,870	14,717,788	+11.0%	Shares	Defined	2023-05-22
2022-12-31	$2,141,996,228	13,254,107	+1.7%	Shares	Defined	2023-02-14
2022-09-30	$1,748,755,088	13,029,991	+0.6%	Shares	Defined	2022-11-14
2022-06-30	$1,984,065,881	12,954,204	+0.4%	Shares	Defined	2022-08-15
2022-03-31	$2,092,368,357	12,907,090	-1.7%	Shares	Defined	2022-05-16
2021-12-31	$1,777,831,378	13,130,217	+25.5%	Shares	Defined	2022-02-14
2021-09-30	$1,128,815,212	10,464,589	+37.3%	Shares	Defined	2021-11-15
2021-06-30	$858,571,475	7,622,261	-9.3%	Shares	Defined	2021-08-16
2021-03-31	$909,949,037	8,408,326	+2.8%	Shares	Defined	2021-05-17
2020-12-31	$876,485,712	8,179,988	+2.7%	Shares	Defined	2021-02-12
2020-09-30	$697,944,358	7,968,311	-0.8%	Shares	Defined	2020-11-16
2020-06-30	$788,483,282	8,030,997	+9.6%	Shares	Defined	2020-08-14
2020-03-31	$558,107,975	7,325,213	—	Shares	Defined	2020-05-15
No filing history on record for this holder in this stock.